Antitrust Challenges To FDA Citizen Petitions: Part 2
In this two-part series, we examine recent antitrust challenges brought by generic firms against branded firms for abuse of the U.S. Food and Drug Administration citizen petition process. In part one,...To view the full article, register now.
Already a subscriber? Click here to view full article